Fidelity International
RMD icon

Fidelity International’s ResMed RMD Stock Holding History

Fidelity International’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.3M Sell
300,025
-148,107
-33% -$36.9M 0.05% 298
2025
Q4 		$108M Sell
448,132
-18,859
-4% -$4.82M 0.08% 225
2025
Q3 		$128M Buy
466,991
+73,058
+19% +$20M 0.1% 199
2025
Q2 		$102M Buy
393,933
+44,199
+13% +$10.5M 0.09% 220
2025
Q1 		$78.3M Sell
349,734
-47,131
-12% -$11M 0.07% 254
2024
Q4 		$90.8M Sell
396,865
-49,529
-11% -$11.9M 0.08% 232
2024
Q3 		$109M Sell
446,394
-334,322
-43% -$74.7M 0.1% 215
2024
Q2 		$149M Sell
780,716
-69,939
-8% -$14.2M 0.15% 169
2024
Q1 		$168M Buy
850,655
+10,625
+1% +$1.95M 0.17% 155
2023
Q4 		$145M Buy
840,030
+597,165
+246% +$91.8M 0.15% 171
2023
Q3 		$35.9M Buy
242,865
+76,107
+46% +$13.8M 0.04% 343
2023
Q2 		$36.4M Hold
166,758
– – 0.04% 344
2023
Q1 		$36.5M Buy
166,758
+27,651
+20% +$6M 0.04% 325
2022
Q4 		$29M Buy
139,107
+16,733
+14% +$3.68M 0.03% 364
2022
Q3 		$26.7M Buy
122,374
+109,571
+856% +$24.9M 0.03% 371
2022
Q2 		$2.68M Buy
12,803
+465
+4% +$99K ﹤0.01% 640
2022
Q1 		$2.99M Buy
+12,338
New +$2.98M ﹤0.01% 649
2021
Q3 		– Sell
-8,291
Closed -$2.04M – 883
2021
Q2 		$2.04M Buy
8,291
+1,549
+23% +$326K ﹤0.01% 703
2021
Q1 		$1.31M Buy
6,742
+3,248
+93% +$651K ﹤0.01% 704
2020
Q4 		$742K Buy
3,494
+317
+10% +$63.2K ﹤0.01% 665
2020
Q3 		$545K Buy
3,177
+2,534
+394% +$468K ﹤0.01% 652
2020
Q2 		$123K Buy
643
+48
+8% +$7.85K ﹤0.01% 662
2020
Q1 		$87K Buy
595
+249
+72% +$39.7K ﹤0.01% 656
2019
Q4 		$54K Buy
346
+334
+2,783% +$48.1K ﹤0.01% 703
2019
Q3 		$2K Hold
12
– – ﹤0.01% 785
2019
Q2 		$1K Buy
12
+2
+20% +$222 ﹤0.01% 852
2019
Q1 		$1K Sell
10
-4
-29% -$413 ﹤0.01% 828
2018
Q4 		$2K Sell
14
-3
-18% -$321 ﹤0.01% 779
2018
Q3 		$2K Buy
+17
New +$1.86K ﹤0.01% 778

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity International's RMD Position: Q1 2026 in Review

Fidelity International reduced its ResMed (RMD) stake by 33% in Q1 2026, selling an estimated $36.9M and leaving 300,025 shares worth $67.3M. The position accounts for 0.05% of the portfolio, ranked #298.

Fidelity International first reported a position in RMD in Q3 2018 and has held it in 29 quarters since. The position peaked at $168M in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Fidelity International held 300,025 shares of ResMed worth $67.3M as of Q1 2026.
  • Fidelity International sold 148,107 ResMed shares in Q1 2026, an estimated $36.9M.
  • ResMed made up 0.05% of Fidelity International's portfolio in Q1 2026, its #298 holding.
  • Fidelity International first reported a position in ResMed in Q3 2018 and has held it in 29 quarters since.
  • Fidelity International's ResMed position peaked at $168M in Q1 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.